Vascular Access Devices – Market Insights – Europe

The European vascular access device market is well-established and will grow marginally over the forecast period. Unit sales will be supported by steady growth in the underlying patient population undergoing medical procedures that require vascular access; however, the maturity of the vascular access device market has resulted in strong downward pressures on ASPs that will somewhat inhibit revenue expansion.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for vascular access devices in Europe from 2019 through 2032.

The COVID-19 pandemic affected procedure volumes and device segments in the vascular access device market.

How have trends in vascular access device segments changed due to COVID-19?

At what pace has the vascular access device market recovered?

New device approvals and other events are impacting the market share dynamics of the vascular access device market.

What mergers and acquisitions are occurring in the vascular access device space, and how are they impacting competitors?

What kinds of new devices are entering the vascular access device market, and how will they affect market and competitive dynamics?

What challenges will new companies encounter in this space? Will they capture significant share from existing competitors?

Companies are making efforts to improve the care of vascular access patients, such as developing innovations that help minimize IV complications.

What kinds of innovations are companies doing to improve the standard of care in patients requiring vascular access?

What are the different securement devices companies are using to enhance patient care?

How are competitors adjusting their strategies to remain competitive in the ever-developing vascular access device market?

Sales of PICCs represent the major contributor to vascular access device market growth.

How is the rising adoption of PICCs impacting the sales of CVC units? How does this vary across Europe?

What is the market forecast for conventional versus power-injectable PICCs?

What are the marketing strategies adopted by companies to promote PICC sales?